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Abstract 
 
Introduction: Mild Cognitive Impairment (MCI) is a transitional entity between normal aging 
and Alzheimer’s disease. It is assumed that an early identification and intervention in MCI may 
delay or slow its progression to dementia and several neuropsychological brief-tests have been 
investigated in this context. The Clock Drawing Test (CDT) is a widely used instrument in this 
field; however, its application needs further validation in specific clinical populations, mainly 
in milder forms of cognitive decline and in the distinction between MCI subtypes. 
 
Objectives:  To validate three scoring systems of the CDT for the detection of cognitive 
impairment in a cohort of MCI-patients previously classified in amnestic single-domain (aMCI) 
and amnestic multidomain (mdMCI) subtypes; to test inter-rater reliability and to compare 
different subtypes of MCI, attempting to define performance profiles according to qualitative 
analyses of errors. 
 
Methods: The study includes two clinical groups: aMCI and mdMCI, each with 90 subjects, 
recruited at the Neurology Department of the Centro Hospitalar e Universitário de Coimbra. 
Their performance was compared with a cohort of 90 community-dwelling controls matched 
according to gender, age and education. All participants were assessed with Mini Mental State 
Examination, Montreal Cognitive Assessment (MoCA) and CDT. Clock drawings of MCI 
patients were scored by a neuropsychologist and an inexperienced rater using three scoring 
systems - Rouleau, Cahn and Babins. Data were analysed with the Statistical Package for the 
Social Sciences. 
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Results:  There was high inter-rater reliability in CDT scoring systems (p<0,001). Significant 
correlations were found between the cognitive screening instruments and CDT scoring systems 
as well as a consistent relationship with performance in visuospatial and executive domains of 
the MoCA. We also observed qualitative differences between both forms of DCL, with higher 
error rate of “Conceptual deficit” and “Perseveration” in mdMCI, and “Nonspecific spatial 
error” regarding the aMCI group. There was only sufficient (60%) discriminatory capacity of 
total scores of the CDT, comparing control and MCI subjects. 
 
Conclusions: Our study showed that CDT scoring systems have high inter-rater reliability to 
screen for MCI and can be applied in large scale studies and primary health care. Although in 
this context CDT revealed only sufficient discriminatory capacity and should be used with other 
cognitive screening tests in order to increase the diagnostic accuracy. 
 
Key-words: Clock Drawing Test, Mild Cognitive Impairment, Reliability, Validity, 
Neuropsychological tests. 
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Resumo 
 
Introdução: O Défice Cognitivo Ligeiro (DCL) é uma entidade transitória entre o 
envelhecimento normal e a demência. Considera-se que o rastreio e intervenção precoces no 
DCL retardam a evolução para demência e diversos testes neuropsicológicos breves têm sido 
propostos tendo em vista este objetivo. O Teste do Desenho do Relógio (TDR) é um 
instrumento vastamente utilizado neste campo, embora a sua aplicação necessite de validação 
suplementar em populações clínicas específicas, principalmente em formas ligeiras de declínio 
cognitivo e na distinção entre subtipos de DCL. 
 
Objectivos: Validar 3 sistemas de cotação do TDR para deteção de défices cognitivos numa 
amostra de pacientes com DCL previamente classificados nos subtipos amnésico monodomínio 
(DCLa) e amnésico multidomínios (DCLmd). Testar a fiabilidade do acordo inter-avaliadores. 
Comparar diferentes subtipos de DCL, para definir perfis de desempenho de acordo com a 
análise qualitativa de erros. 
 
Métodos: Este estudo incluiu dois grupos clínicos: DCLa e DCLmd, cada um com 90 pacientes 
recrutados no Serviço de Neurologia do Centro Hospitalar e Universitário de Coimbra. Os 
desempenhos foram comparados com uma amostra de 90 cidadãos, emparelhados de acordo 
com género, idade e escolaridade. Todos os participantes foram avaliados com Mini Mental 
State Examination, Montreal Cognitive Assessment (MoCA) e TDR. Os desenhos de relógios 
de pacientes com DCL foram cotados por um neuropsicólogo e um avaliador inexperiente, 
utilizando 3 sistemas de cotação: Rouleau, Cahn e Babins. Os dados foram analisados com 
recurso ao Statistical Package for the Social Sciences. 
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Resultados: Verificou-se elevado acordo inter-avaliadores no TDR (p<0,001). Foram 
encontradas correlações significativas entre os instrumentos de rastreio cognitivo e os sistemas 
de cotação do TDR, assim como uma relação consistente com os domínios visuoespacial e 
executivo do MoCA. Foram encontradas diferenças qualitativas entre as formas de DCL, com 
elevada taxa de erro no “Défice Conceptual” e ”Preserveração” no DCLmd e no “Erro espacial 
não específico” no DCLa. Os resultados totais do TDR apresentaram apenas uma capacidade 
discriminatória suficiente (60%) na distinção entre controlos e DCL. 
 
Conclusões: Este estudo mostrou que os sistemas de cotação do TDR têm elevada fiabilidade 
inter-avaliadores para rastrear DCL e podem ser aplicados em estudos de larga escala e em 
cuidados de saúde primários. No entanto, neste contexto, o TDR revelou uma capacidade 
discriminatória apenas suficiente e deve ser utilizado juntamente com outros instrumentos de 
rastreio cognitivo com o objetivo de aumentar a precisão diagnóstica. 
 
Palavras-chave: Teste do Desenho do Relógio, Défice Cognitivo Ligeiro, Fidelidade, 
Validade, Testes Neuropsicológicos. 
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Introduction 
 
Mild Cognitive Impairment (MCI) is a transitional entity between normal aging and 
Alzheimer’s disease (AD), hence the discrimination between normal aging and pathology is 
frequently a difficult challenge
1-4
. It is considered both an incipient stage of dementia and a 
situation of risk for its development, though this progression does not always occur. About 10-
15% per year and 80% over 6 years of these patients develop some type of dementia
5
. Some 
predictors of conversion from MCI to AD have been identified, including neuropsychological 
testing, neuroimaging and biomarkers, alone or in combination. It is clinically defined as a self 
or informant-reported cognitive complaint and an objective cognitive impairment that surpasses 
what is expectable in subjects with a certain age and education, while functional activities of 
daily living remain relatively intact.  
 Different subtypes of MCI are recognized. While amnestic MCI (single or multiple 
domain) is considered to be the prodromic stage of AD and there is controversy about the impact 
of this profile impairment (aMCI vs. mdMCI) in prognosis.  Nonamnestic forms of MCI (single 
or multiple domain) express other types of cognitive impairment, namely language or executive 
functions and visuospatial abilities, representing prodromic stages of other forms of dementia, 
respectively Frontotemporal Dementia Vascular Dementia or Dementia with Lewy Bodies
2,3
. 
It is assumed that an early identification and intervention in MCI may delay or slow its 
progression to dementia. This identification in primary care centres depends on the 
development of brief cognitive screening instruments, easily applicable and properly validated. 
The Clock Drawing Test (CDT), included in the Montreal Cognitive Assessment (MoCA) and 
several neuropsychological test batteries, is a globally recognized instrument in this field, but 
its application requires more studies in specific clinical populations. It is already normalized 
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for the Portuguese population according to age and education
6
, but further validation in clinical 
groups with MCI is still needed. 
In spite of its wide usage in distinguishing normal aging from subjects with MCI, the 
academic literature lacks consensus on the sensitivity and specificity of the CDT as a screening 
tool for MCI, if used alone, contrarily to what happens in moderate and severe dementia
7
. 
Differences in scoring systems are also a subject of discussion. This makes the CDT of doubtful 
recommendation for MCI screening
8
. 
The aim of this study was to validate the CDT for the detection of cognitive impairment 
in a group of patients previously diagnosed with MCI, whose performance was compared with 
a cohort of cognitively normal individuals, according to age and education. We also tested inter-
rater reliability and compared different subtypes of MCI, attempting to define performance 
profiles according to qualitative analyses of errors. 
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Methods 
 
Participants 
The clinical group was composed of ambulatory patients from the Neurology 
Department of the Centro Hospitalar e Universitário de Coimbra (CHUC). MCI diagnosis was 
previously established by the attending Neurologist according to Petersen criteria: memory 
complaints (preferably confirmed by an informant), preserved global cognition, activities of 
daily living essentially preserved, objective memory deficit according to age, and no 
dementia
1,9
. Clinical diagnosis was further supported by comprehensive neuropsychological 
assessment and extensive biochemical and image studies in order to exclude other causes for 
cognitive impairment. In the selection of MCI patients the following exclusion criteria were 
also considered: a) psychiatric comorbidities diagnosed less than six months prior to the 
neuropsychological study assessment; b) motor and/or sensory deficits that could represent 
confounding variables in the assessment of higher nervous functions; c) unstable clinical 
situation (e.g., recent significant deterioration). 
Controls were community-dwellings integrating the CDT normative study sample
6
. In 
brief, they were recruited according to the following criteria: 
a) Informed consent; 
b) Portuguese as mother language and formal education received in Portuguese schools; 
c) Normal score according to age and education on two cognitive screening instruments 
validated for the Portuguese population, the Mini-Mental State Examination (MMSE) 
and the MoCA; 
d) Preserved independence and functionality; 
e) No severe depressive symptomatology (Geriatric Depression Scale-30 item score ≤20); 
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f) No history of psychiatric, neurologic or other diseases with a negative impact on 
cognition; 
g) No medication with a negative impact on cognition; 
h) No significant motor, visual or auditory deficits with a possible negative impact on 
cognition; 
i) No present or past history of alcoholism or drug abuse. 
 
Instruments 
For the assessment of global cognitive function we used the MMSE
10-12 
and the 
MoCA
13,14
. 
The MMSE is the most widely used cognitive screening instrument for dementia. It 
assesses several cognitive domains with a set of questions and tasks: orientation, memory, 
attention and calculus, language (oral, written and reading), and constructive abilities. Each of 
the subtests is scored according to norms established by the authors, with a maximum of 30 
points
10
. The Portuguese validation and normalization considered the significant effects of 
education, and cut-off scores for cognitive impairment were proposed accordingly: illiterates – 
≤ 15; 1 to 11 years – ≤ 22; more than 11 years – ≤ 27
11
. 
The MoCA is a cognitive screening instrument created by Nasreddine
13
 for the 
detection of MCI, as the MMSE systematically revealed a low sensitivity in patients with milder 
forms of cognitive impairment. The instrument has a total score of 30 points and assesses six 
cognitive domains through different tasks: short-term memory (delayed recall task, 5 points); 
visuospatial abilities (clock drawing, 3 points; cube copy, 1 point); executive functions (trail-
making test B adapted, 1 point; phonemic verbal fluency, 1 point; verbal abstraction, 2 points); 
attention, concentration and working memory (A’s detection, 1 point; serial subtractions, 3 
points; digit span, 2 points); language (naming, 3 points; sentence repetition, 2 points); and 
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orientation (day, month, year, week day, place, and city, 6 points)
13,14
. The MoCA is 
normalized for the Portuguese population and there are norms according to age and education 
for subjects with 25 years of age and older
15
. 
Finally, the CDT was scored according to the three scoring systems currently validated 
for the Portuguese population: the Rouleau
16
 10-point quantitative system; the Cahn
17
 system 
which combines the Rouleau quantitative score with the analysis of the 8 more common types 
of error that occur during clock drawing
18
; and the Babins
19
 18-point scoring system. The 
instructions given to the participants were the following: “I want you to draw a round clock, 
place all the numbers, and set the time for ten past eleven”. The word “hands” and “minutes” 
should have been avoided in all cases as they could constitute hints for the execution process. 
 
Procedures 
All study participants in the MCI group were assessed by certified and experienced 
neuropsychologists, and the final neuropsychological diagnosis was validated by the Head of 
the Laboratory of Higher Nervous Functions of the CHUC. All clock drawings from both the 
clinical and control groups were scored by one Neuropsychologist, thus minimizing the risk of 
differences in CDT scores attributable to interpersonal factors. Additionally, a subgroup of 
protocols was scored by an independent inexperienced rater previously trained by the 
responsible Neuropsychologist in order to assess inter-rater reliability.  
Complete methods for the selection and assessment of control subjects can be found in 
Santana
6
. 
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Statistical analysis 
Statistical analyses were performed using the Statistical Package for the Social Sciences 
(SPSS, version 19.0) and a p value of 0,05 was considered statistically significant. Descriptive 
statistics were used for sample’s characterization and two-sample t-test as well as independence 
qui-square (χ2) test allowed the group comparisons. The inter-rater reliability was calculated 
using the Pearson correlation coefficient between the scoring of two independent raters. The 
convergent validity was determined using Pearson correlations coefficients between the CDT, 
MoCA and MMSE scores. The group differences were examined using two-sample t-test, 
analysis of variance (ANOVA) and analysis of covariance (ANCOVA). 
The diagnostic accuracy of the CDT scoring systems for the prediction of the clinical 
diagnosis of MCI (as well as subtypes of MCI) was assessed through the receiver operating 
characteristics (ROC) curve analysis. In this analysis, the area under the curve (AUC) can vary 
between 0.5 and 1 and a larger AUC indicates better diagnostic accuracy. The optimal cut-off 
points for each scoring system that yielded the highest Youden index were selected, with the 
higher value indicating maximization of sensitivity and specificity. For the analysis of the 
predictive value of this test we calculated, for each cut-off point, the sensitivity (the probability 
for subjects with cognitive impairment to have a positive test), specificity (the probability for 
subjects without cognitive impairment to have a negative test), positive predictive value (PPV, 
the probability of disease in subjects who have a positive test), negative predictive value (NPV, 
probability of the classification “lack of disease” in subjects who have a negative test) and 
classification accuracy (probability of correct classification of subjects with or without 
cognitive impairment). 
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Results 
 
The final study sample was composed of 270 subjects, distributed equally amongst three 
groups: 90 amnestic (single domain) MCI subjects (aMCI), 90 amnestic multidomain subjects 
(mdMCI), and 90 control subjects (CNT). In the selection process, all participants were matched 
according to gender, age and education. The total sample had 141 females (52,2%), a mean age 
of 69,39 (±7,32) years and 7,93 (±4,54) years of education. Additionally, the participants in the 
MCI groups had a mean age at onset of cognitive complaints of 66,42 (±7,54) years. As 
expected, there were no gender distribution differences between the three groups (χ2=0,000, 
p=1,000), as well as no differences in age (F(2,267)=0,232, p=0,793), education (F(2,267)=0,088, 
p=0,915), or age of onset (t(137)=1,146, p=0,254). A complete description of the demographic 
variables from the study samples can be found in Table 1. 
 
Table 1. Demographic variables 
 aMCI mdMCI CNT Group differences 
Gender (%females) 47 (52,2%) 47 (52,2%) 47 (52,2%) χ2= 0,000, p=1,000 
Age 69,37 (7,38) 69,77 (7,47) 69,02 (7,19) F(2,267)= 0,232, p=0,793 
Education 7,87 (4,49) 8,09 (4,71) 7,82 (4,47) F(2,267)= 0,088, p=0,915 
Age of onset 65,68 (7,40) 67,14 (7,65) N/A t(137)=1,146, p=0,254 
Note: Results are presented as mean (standard deviation) except for gender. 
 
Inter-rater reliability was assessed in a subgroup of 70 randomly selected MCI subjects 
that were scored by two independent raters. We found high significant correlations (Pearson’s 
R) between total scores of both raters for the three scoring systems: Rouleau – r=0,895, 
p≤0,001; Cahn – r=0,871, p≤0,001; and Babins – r=0,897, p≤0,001. 
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There were moderate to high significant correlations between the cognitive screening 
instruments and the CDT scoring systems (Table 2). As for demographic variables of interest, 
we found significant low negative correlations between all scoring systems and age, as well as 
low to moderate significant correlations with education (Table 2). 
 
Table 2. Correlation between the MMSE, MoCA and CDT scoring systems 
 Education MMSE MoCA Rouleau Cahn Babins 
Age 0,133* -0,049 -0,107 -0,167** -0,164** -0,153* 
MMSE 0,261*** ----- 0,625*** 0,320*** 0,335*** 0,350*** 
MoCA 0,416*** 0,625*** ----- 0,424*** 0,437*** 0,502*** 
Rouleau 0,279*** 0,320*** 0,424*** ----- 0,979*** 0,941*** 
Cahn 0,269*** 0,335*** 0,437*** 0,979*** ----- 0,929*** 
Babins 0,354*** 0,350*** 0,502*** 0,941*** 0,929*** ---- 
*** Significant at the 0,001 level 
** Significant at the 0,01 level 
* Significant at the 0,05 level 
 
We performed an ANOVA in order to analyze the differences between the groups in the 
MMSE, MoCA and CDT scoring systems. We found significant differences in the MMSE 
(F(2,267)=13,503, p≤0,001), MoCA (F(2,213)=26,798, p≤0,001), Rouleau (F(2,267)=5,976, p≤0,01), 
Cahn (F(2,266)=7,729, p≤0,001), and Babins scoring systems (F(2,267)=4,278, p≤0,05). Post hoc 
analyses are described in Table 3. 
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Table 3. Group differences in MMSE, MoCA, and CDT scoring systems 
 aMCI mdMCI CNT Group comparisons p 
MMSE 27,81 (2,21) 27,18 (1,92) 28,63 (1,44) 
CNT > aMCI 
CNT > mdMCI 
0,010 
0,000 
MoCA 20,63 (3,76) 19,35 (3,50) 23,58 (3,43) CNT > aMCI, mdMCI 0,000 
Rouleau 8,08 (1,84) 7,29 (1,99) 8,24 (2,10) 
CNT > aMCI 
aMCI > mdMCI 
0,004 
0,022 
Cahn 6,97 (2,64) 5,78 (2,85) 7,34 (2,87) 
CNT > mdMCI 
aMCI > mdMCI 
0,001 
0,013 
Babins 13,82 (3,81) 12,87 (3,53) 14,46 (3,66) CNT > mdMCI 0,011 
Note: Results are presented as mean (standard deviation). 
 
Considering the significant effect of age and education in all tests’ scores, we performed 
an ANCOVA using as covariates both demographic variables. We confirmed a significant 
effect of diagnosis in all scoring systems, as well as MMSE and MoCA scores (Table 4). 
 
Table 4. Analysis of covariance: effect of Diagnosis in tests’ scores (covariates: age and 
education) 
  F Sig. R2 Partial Eta square Observed power 
MMSE 14,953 0,000 0,169 0,101 0,998 
MoCA 37,705 0,000 0,411 0,263 1,000 
Rouleau 6,776 0,001 0,163 0,049 0,917 
Cahn 8,718 0,000 0,168 0,062 0,969 
Babins 5,200 0,006 0,198 0,038 0,827 
 Afterwards we explored the differences between the groups regarding subjective errors 
included in the Cahn scoring system. We found significant differences in “Conceptual deficit”, 
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with the mdMCI and CNT groups having a significantly higher error rate than the aMCI group 
(χ2=13,034, p≤0,001); the mdMCI group also had a significantly higher rate of “Perseveration” 
errors than the other two groups (χ2=6,067, p≤0,05); finally, regarding “Non specific spatial 
error”, the aMCI group had a significantly higher error rate that the CNT group (χ2=8,258, 
p≤0,05). There were no significant differences regarding any of the other subjective errors. 
In order to analyze the relationship between the CDT and different cognitive areas, we 
performed correlation analyses between the three scoring systems and the cognitive domains 
assessed by the MoCA. We found different results according to each group, but there was a 
common significant relationship between the CDT, visuospatial abilities, and executive 
functions. The results for each group are detailed in Tables 5, 6 and 7. 
 
Table 5. Correlation between the CDT scoring systems and MoCA cognitive domains – aMCI 
 Memory Visuospatial 
abilities 
Executive 
functions 
Attention/ 
C/WM 
Language Orientation 
Rouleau 0,188 0,755** 0,245* 0,181 0,027 0,250* 
Cahn 0,173 0,730** 0,224 0,185 0,006 0,258* 
Babins 0,239* 0,804** 0,362** 0,246* 0,083 0,207 
Note: Attention/C/WM (Attention, Concentration and Working Memory) 
** Significant at the 0,001 level 
* Significant at the 0,05 level 
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Table 6. Correlation between the CDT scoring systems and MoCA cognitive domains – mdMCI 
 Memory Visuospatial 
abilities 
Executive 
functions 
Attention/ 
C/WM 
Language Orientation 
Rouleau -0,179 0,723** 0,284* 0,113 0,392** -0,224 
Cahn -0,139 0,689** 0,299* 0,103 0,347* -0,200 
Babins -0,175 0,699** 0,305* 0,176 0,440** -0,220 
Note: Attention/C/WM (Attention, Concentration and Working Memory) 
** Significant at the 0,001 level 
* Significant at the 0,05 level 
 
Table 7. Correlation between the CDT scoring systems and MoCA cognitive domains – CNT 
 Memory Visuospatial 
abilities 
Executive 
functions 
Attention/ 
C/WM 
Language Orientation 
Rouleau -0,057 0,699** 0,451** 0,337** 0,215* 0,111 
Cahn -0,057 0,731** 0,478** 0,361** 0,209* 0,106 
Babins -0,039 0,759** 0,550** 0,354** 0,284** 0,114 
Note: Attention/C/WM (Attention, Concentration and Working Memory) 
** Significant at the 0,001 level 
* Significant at the 0,05 level 
 
The diagnostic/discriminative capacity of the CDT was determined by using ROC curve 
analysis; sensitivity and specificity values, as well as the optimal cut-off points were determined 
by using Youden index. When distinguishing CNT from all MCI subjects, we found an AUC 
of 0,614, 0,623 and 0,623 for the Rouleau, Cahn and Babins scoring systems total scores, 
respectively (Figure 1). The optimal cut-off score for the Rouleau system was 9 points, with 
86% sensitivity and 34% specificity; for the Cahn system a cut-off score of 8 points represented 
55% sensitivity and 66% specificity; as for the Babins system, a cut-off score of 15 points 
18 
 
showed 53% sensitivity and 70% specificity (Annex 1). The PPV, NPV and diagnostic accuracy 
values for each scoring system are presented in Table 8. 
 
Figure 1. ROC curve analysis: CNT vs MCI. 
 
Table 8. Sensitivity, specificity, PPV, NPV and diagnostic accuracy of the CDT: CNT vs. MCI. 
  Positive Negative PPV/NPV Accuracy 
Rouleau 
Presence 86 66 57 
60% 
Absence 14 34 71 
  Positive Negative PPV/NPV Accuracy 
Cahn 
Presence 55 33 63 
61% 
Absence 45 66 59 
  Positive Negative PPV/NPV Accuracy 
Babins 
Presence 53 30 64 
62% 
Absence 47 70 60 
 
Next we examined the discriminative capacity of the CDT regarding both subtypes of 
MCI separately. When comparing CNT and aMCI subjects, we found an AUC of 0,556, 0,565, 
and 0,575 for the Rouleau, Cahn and Babins systems, respectively (Figure 2). The optimal cut-
off score for the Rouleau system was 9 points, with 78% sensitivity and 34% specificity; for 
the Cahn system a cut-off score of 8 points represented 73% sensitivity and 40% specificity; as 
for the Babins system, a cut-off score of 14 points showed 43% sensitivity and 70% specificity 
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(Annex 2). The PPV, NPV and diagnostic accuracy values for each scoring system are presented 
in Table 9. 
 
Table 9. Sensitivity, specificity, PPV, NPV and diagnostic accuracy of the CDT: CNT vs. aMCI. 
  Positive Negative PPV/NPV Accuracy 
Rouleau 
Presence 78 66 54 
56% 
Absence 22 34 61 
  Positive Negative PPV/NPV Accuracy 
Cahn 
Presence 73 60 55 
57% 
Absence 27 40 60 
  Positive Negative PPV/NPV Accuracy 
Babins 
Presence 43 30 59 
57% 
Absence 57 70 55 
 
 
When comparing CNT and mdMCI subjects, we found an AUC of 0,672, 0,680, and 
0,671 for the Rouleau, Cahn and Babins systems, respectively (Figure 3). The optimal cut-off 
score for the Rouleau system was 9 points, with 93% sensitivity and 34,4% specificity; for the 
Cahn system a cut-off score of 8 points represented 64% sensitivity and 66% specificity; as for 
the Babins system, a cut-off score of 15 points showed 62% sensitivity and 70% specificity 
Figure 2. ROC curve analysis: CNT vs aMCI. 
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(Annex 3). The PPV, NPV and diagnostic accuracy values for each scoring system are presented 
in Table 10. 
 
 
 
Table 10. Sensitivity, specificity, PPV, NPV and diagnostic accuracy of the CDT: CNT vs. mdMCI. 
  Positive Negative PPV/NPV Accuracy 
Rouleau 
Presence 93 66 58 
64% 
Absence 7 34 83 
  Positive Negative PPV/NPV Accuracy 
Cahn 
Presence 64 34 65 
65% 
Absence 36 66 65 
  Positive Negative PPV/NPV Accuracy 
Babins 
Presence 62 30 67 
66% 
Absence 38 70 65 
 
 
 
 
 
 
 
Figure 3. ROC curve analysis: CNT vs. mdMCI. 
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Discussion and Conclusions 
 
MCI is still now a controversial entity, considered by some authors as a situation of high 
risk for the development of dementia and AD, and assumed by others as prodromic AD. This 
ambivalence is reflected in the most recent diagnostic criteria: the NIA-AAWG (National 
Institute on Aging- Alzheimer´s disease Work Group
4
), considers that the MCI-group  with a 
biomarker-profile of AD is still in a pre-dementia high risk stage and propose the designation 
of “MCI due to AD” for these patients. According to the recent European proposal - Advancing 
research diagnostic criteria for Alzheimer’s disease: IWG-2 criteria
20
, MCI-patients presenting 
evidence of tau and amyloid pathology or harbouring an AD-related mutation on chromosomes 
1, 14 or 21, are already classified as Typical AD. There is also controversy about the impact of 
the profile impairment (aMCI vs. mdMCI) in prognosis. Some studies indicate that the most 
relevant neuropsychological predictor of conversion to dementia is the severity of the memory 
impairment
21
, while others consider a multidomain involvement as the stronger indicator of 
conversion
22
. 
 We present a validation study of the CDT in specific groups of MCI patients (amnestic 
vs. amnestic/multidomain), whose performance was compared with a control group selected 
from the Portuguese normative study population
6
. This study had a large sample, almost 
perfectly matched between the three groups regarding major demographic variables (gender, 
age and education), which increased the reliability of results. Considering the study groups, 
they can be deemed as representative because demographic characteristics are equivalent to 
previously published cohorts, namely in terms of median age and female gender dominance. 
Educational level, although lower than usually observed in cohorts from USA or northern 
Europe, is typical of our geriatric population.   
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One aim of this study was to test inter-rater reliability. We verified parallel results 
between an experienced and a non-experienced rater, a fact that supports the reliability of 
quotation systems and their application in clinical practice by health professionals with no 
major experience in neuropsychology. As a brief and easily applicable test, the CDT can be 
safely used in large scale, mainly in primary care centres as an additional instrument for the 
screening of cognitive impairment. Previous studies also showed that most of the existing CDT 
scoring systems have inter-rater reliability above 90% to screen for moderate and severe 
dementia
7,23
 and similar values for mild Alzheimer’s Disease
24,25
. Our results expanded these 
conclusions to cohorts of patients with milder forms of cognitive decline. 
All three scoring systems presented moderate significant correlations with other 
cognitive screening instruments analysed. This relationship was stronger with the MoCA, 
which is explained by the recruitment of multiple brain areas or cognitive functions while 
performing the CDT, mainly executive functions, which are not assessed by the MMSE. Similar 
to our results, Mainland and collaborators
26
 also found significant correlations between the 
CDT and the MMSE, using different quotation systems (e.g., Shulman and Babins), although 
with little impact in the MCI-diagnosis.  
The MoCA is generally considered more sensitive and specific in screening dementia 
or MCI than the MMSE
27
 and the same results were found in studies concerning Portuguese 
population
15
. In addition, when comparing MoCA, MMSE and the CDT, the first one proved 
to be the most appropriate tool to screen MCI and in differentiating it from AD and from normal 
ageing
28
. Our study corroborated these results, confirming the superiority of the MoCA 
relatively to the CDT and the MMSE. 
Similar to other instruments of neuropsychological assessment, in this study the CDT 
showed significant correlations with demographic variables of interest, particularly education. 
However, since this effect was controlled (together with age), the variable diagnosis (CNT vs. 
23 
 
aMCI vs. mdMCI) maintained a significant effect on the test results. Age and education have 
been proved to be very important variables with a significant effect on cognitive screening 
instruments
29,30
. It is known that lower education can even compromise the results on the CDT 
as is reflected in very low normative scores in individuals with less than 4 years of formal 
education
31
. For the Portuguese population, cut-off points according to age and education were 
recently defined which allowed a more accurate use of the CDT as a brief cognitive screen test
6
. 
Nonetheless, carefulness it is still suggested when interpreting CDT results in elder and people 
with low education based exclusively in global quantitative scores. 
Concerning differences between the analysed groups, we verified an overall trend 
towards a superiority of the performance of control subjects with respect to MCI individuals. 
However, when we analysed aMCI and mdMCI separately, the mdMCI group showed a 
significantly poorer performance than the aMCI group, a difference that was not detected by 
standard screening instruments (MMSE and MoCA). Previous neuropsychological studies 
compared the performance of CDT between normal population, MCI and AD
32
, but not 
between different subtypes of MCI. Few studies have attempted to distinguish subtypes of MCI 
patients, although they used more developed instruments or techniques, such as Event Related 
Potentials in the Simon Task
33
. The Cahn scoring system, as a qualitative measure, was 
important to identify the pattern of errors made by each subtype of MCI, with “Conceptual 
Deficit” and “Perseveration” more typical of mdMCI, and “Nonspecific spatial error” with a 
higher error rate committed by aMCI patients.  
Differences between MCI subtypes were further enhanced by the correlation with 
several cognitive domains (sets of specific MoCA subtests). As was previously described
34
, we 
confirmed the importance of executive functions and visuospatial abilities in the CDT 
performance. This correlation with visual and executive functions is shared by the three groups. 
24 
 
Other results also appeared interesting: first, in CNT group there was a high correlation with 
the attention domain, including concentration and working memory, which did not happen in 
any MCI subtype; second, correlation with language domain is shared with MCI-md; third, 
orientation skills and CDT were only significantly correlated in the aMCI group. We do not 
have a global explanation for these findings, but we can speculate that these are critical domains 
in the respective groups: attention and working memory are cognitive functions specially 
vulnerable to normal-aging, while functions specially vulnerable to AD-pathology like 
language, may be correlated in study groups. On the other hand, there were no significant 
correlations with memory performance which is a clear demonstration of the independence of 
the CDT relatively to this function.  
ROC curve analysis demonstrated a poor discriminative capacity of total scores of the 
CDT between control and MCI subjects. This is specially true but also predictable for the 
amnesic sub-type considering that there were no correlations between memory and CDT 
performance. This evidence reinforces the hypothesis that this instrument, when used 
individually and based on overall scores, will have a limited clinical interest in the detection of 
typical MCI due to Alzheimer’s disease. Despite the different sensitivity and specificity values 
between the three systems, their diagnostic accuracy is very similar, slightly higher for the 
Babins system. According to the literature, the individual use of CDT has good screening 
precision in moderate and severe dementia, but not in MCI
7,8,35
. 
For the screening of milder cognitive decline, it is suggested that the CDT may be 
applied as part of larger assessment protocols
25
, and/or in association with other cognitive 
screening tests like the MMSE
23,36
, but this association is still under development and more 
studies are needed to demonstrate its efficacy. 
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Annex 1 – ROC curve analysis: CNT vs. MCI 
CNT vs MCI 
Test Result 
Variable(s) 
Coordinates of the Curve    
Positive if Less Than or Equal To Sensitivity 1 - Specificity Youden 
Rouleau 1,00 0,000 0,000 0,000 
 2,50 0,006 0,022 -0,017 
 3,50 0,050 0,044 0,006 
 4,50 0,073 0,067 0,006 
 5,50 0,179 0,167 0,012 
 6,50 0,246 0,200 0,046 
 7,50 0,369 0,222 0,146 
 8,50 0,547 0,378 0,170 
 9,50 0,855 0,656 0,199 
 11,00 1,000 1,000 0,000 
Cahn -3,00 0,000 0,000 0,000 
 -1,50 0,006 0,000 0,006 
 -0,50 0,011 0,000 0,011 
 0,50 0,039 0,033 0,006 
 1,50 0,067 0,033 0,034 
 2,50 0,117 0,133 -0,016 
 3,50 0,184 0,156 0,029 
 4,50 0,257 0,200 0,057 
 5,50 0,318 0,200 0,118 
 6,50 0,413 0,244 0,169 
 7,50 0,553 0,344 0,209 
 8,50 0,799 0,600 0,199 
 9,50 0,866 0,711 0,155 
  11,00 1,000 1,000 0,000 
Babins 2,00 0,000 0,000 0,000 
 3,50 0,006 0,000 0,006 
 4,50 0,022 0,000 0,022 
 5,50 0,045 0,033 0,011 
 6,50 0,084 0,044 0,039 
 7,50 0,128 0,078 0,051 
 8,50 0,145 0,144 0,001 
 9,50 0,196 0,167 0,029 
 10,50 0,212 0,178 0,035 
 11,50 0,223 0,178 0,046 
 12,50 0,296 0,211 0,085 
 13,50 0,358 0,256 0,102 
 14,50 0,525 0,300 0,225 
 15,50 0,626 0,444 0,181 
 16,50 0,821 0,644 0,177 
 17,50 0,978 0,867 0,111 
  19,00 1,000 1,000 0,000 
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Annex 2 – ROC curve analysis: CNT vs. aMCI 
CNT vs aMCI 
Test Result 
Variable(s) 
Coordinates of the Curve 
Positive if Less Than or Equal To 
   
Sensitivity 1 - Specificity Youden 
Rouleau 1,00 0,000 0,000 0,000 
 2,50 0,000 0,022 -0,022 
 3,50 0,034 0,044 -0,011 
 4,50 0,045 0,067 -0,022 
 5,50 0,135 0,167 -0,032 
 6,50 0,191 0,200 -0,009 
 7,50 0,303 0,222 0,081 
 8,50 0,449 0,378 0,072 
 9,50 0,775 0,656 0,120 
  11,00 1,000 1,000 0,000 
Cahn -1,00 0,000 0,000 0,000 
 0,50 0,034 0,033 0,000 
 1,50 0,045 0,033 0,012 
 2,50 0,067 0,133 -0,066 
 3,50 0,146 0,156 -0,009 
 4,50 0,191 0,200 -0,009 
 5,50 0,236 0,200 0,036 
 6,50 0,326 0,244 0,081 
 7,50 0,461 0,344 0,116 
 8,50 0,730 0,600 0,130 
 9,50 0,798 0,711 0,087 
  11,00 1,000 1,000 0,000 
Babins 3,00 0,000 0,000 0,000 
 4,50 0,022 0,000 0,022 
 5,50 0,045 0,033 0,012 
 6,50 0,090 0,044 0,045 
 7,50 0,146 0,078 0,068 
 8,50 0,169 0,144 0,024 
 9,50 0,180 0,167 0,013 
 11,00 0,180 0,178 0,002 
 12,50 0,225 0,211 0,014 
 13,50 0,281 0,256 0,025 
 14,50 0,427 0,300 0,127 
 15,50 0,551 0,444 0,106 
 16,50 0,742 0,644 0,097 
 17,50 0,955 0,867 0,088 
  19,00 1,000 1,000 0,000 
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Annex 3 – ROC curve analysis: CNT vs. mdMCI 
CNT vs mdMCI 
Test Result 
Variable(s) 
Coordinates of the Curve    
Positive if Less Than or Equal To Sensitivity 1 - Specificity Youden 
Rouleau 1,00 0,000 0,000 0,000 
 2,50 0,011 0,022 -0,011 
 3,50 0,067 0,044 0,022 
 4,50 0,100 0,067 0,033 
 5,50 0,222 0,167 0,056 
 6,50 0,300 0,200 0,100 
 7,50 0,433 0,222 0,211 
 8,50 0,644 0,378 0,267 
 9,50 0,933 0,656 0,278 
  11,00 1,000 1,000 0,000 
Cahn -3,00 0,000 0,000 0,000 
 -1,50 0,011 0,000 0,011 
 -0,50 0,022 0,000 0,022 
 0,50 0,044 0,033 0,011 
 1,50 0,089 0,033 0,056 
 2,50 0,167 0,133 0,033 
 3,50 0,222 0,156 0,067 
 4,50 0,322 0,200 0,122 
 5,50 0,400 0,200 0,200 
 6,50 0,500 0,244 0,256 
 7,50 0,644 0,344 0,300 
 8,50 0,867 0,600 0,267 
 9,50 0,933 0,711 0,222 
  11,00 1,000 1,000 0,000 
Babins 2,00 0,000 0,000 0,000 
 3,50 0,011 0,000 0,011 
 4,50 0,022 0,000 0,022 
 5,50 0,044 0,033 0,011 
 6,50 0,078 0,044 0,033 
 7,50 0,111 0,078 0,033 
 8,50 0,122 0,144 -0,022 
 9,50 0,211 0,167 0,044 
 10,50 0,244 0,178 0,067 
 11,50 0,267 0,178 0,089 
 12,50 0,367 0,211 0,156 
 13,50 0,433 0,256 0,178 
 14,50 0,622 0,300 0,322 
 15,50 0,700 0,444 0,256 
 16,50 0,900 0,644 0,256 
 17,50 1,000 0,867 0,133 
  19,00 1,000 1,000 0,000 
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